Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (1) Daumke, Oliver Prof. Dr. (26) Dechend, Ralf Priv. Doz. (1) Fälber, Katja Dr. (5) Gavvovidis, Ioannis Dr. (1) Gerhardt, Holger Prof. Dr. (1) Haucke, Volker Professor (3) Hinz, Michael Dr. (1) Höpken, Uta Elisabeth PD Dr. (1) Hübner, Norbert Prof. Dr. (1) Kammertöns, Thomas Dr. (2) Kettenmann, Helmut Prof. Dr. (1) Kettritz, Ralph Prof. Dr. (1) Kunz, Severine Dr. (3) Lorenz, Felix Dr. (2) Müller, Dominik Prof. Dr. (1) Müller, Gerd Dr. (1) Noel, Jeffrey Dr. (2) Obenaus, Matthias (1) Patone, Giannino Dr. (1) Rocks, Oliver Dr. (3) Roske, Yvette Dr. (1) Schlegel, Jeanette (1) Selbach, Matthias Prof. Dr. (1) Szymborska-Mell, Anna Bozena Dr. (1) Uckert, Wolfgang Prof. Dr. (28) Willimsky, Gerald Dr. (1) Yilmaz, Zekiye Buket Dr. (1) Zauber, Henrik Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (6) (-) Bunse, Mario Dr. (3) (-) Leisegang, Matthias Dr. (10) (-) Mathas, Stephan Dr. (1) 1998 (2) 2000 (2) 2003 (4) 2004 (1) 2005 (3) 2006 (2) 2007 (1) 2008 (2) (-) 2010 (4) (-) 2011 (2) 2012 (3) (-) 2013 (3) 2014 (3) (-) 2015 (3) 2016 (5) (-) 2017 (3) 2018 (1) 2019 (2) 2021 (1) Biology of Malignant Lymphomas (20) Cancer Genetics and Cellular Stress Responses (1) Genetics and Genomics of Cardiovascular Diseases (1) Integrative Vascular Biology (1) (-) Molecular Cell Biology and Gene Therapy (14) Molecular Immunology and Gene Therapy (32) Signal Transduction in Tumor Cells (1) (-) Structural Biology of Membrane-Associated Processes (1) Systems Biology of Gene Regulatory Elements (1) 15 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Bunse, Mario Dr.Leisegang, Matthias Dr.Mathas, Stephan Dr.Molecular Cell Biology and Gene TherapyStructural Biology of Membrane-Associated Processes20102011201320152017 Sort: Result score Newest to oldest Oldest to newest July 01, 2017 in Canc Res Chimeric PD-1:28 receptor upgrades low-avidity T cells and restores effector function of tumor-infiltrating lymphocytes for adoptive cell therapy R. Schlenker L.F. Olguín-Contreras M. Leisegang J. Schnappinger A. Disovic S. Rühland P.J. Nelson H. Leonhardt H. Harz S. Wilde D.J. Schendel W. Uckert G. Willimsky E. Noessner May 04, 2017 in Nature Tumour ischaemia by interferon-γ resembles physiological blood vessel regression T. Kammertoens C. Friese A. Arina C. Idel D. Briesemeister M. Rothe A. Ivanov A. Szymborska G. Patone S. Kunz D. Sommermeyer B. Engels M. Leisegang A. Textor H.J. Fehling M. Fruttiger M. Lohoff A. Herrmann H. Yu R. Weichselbaum W. Uckert N. Hübner H. Gerhardt D. Beule H. Schreiber T. Blankenstein April 01, 2017 in Mol Cell Biol Activation-dependent TRAF3 exon 8 alternative splicing is controlled by CELF2 and hnRNP C binding to an upstream intronic element A.S. Schultz M. Preussner M. Bunse R. Karni F. Heyd June 01, 2015 in BIOspektrum Designer T cells - New possibilities for immunotherapy of cancer [Designer-T-Zellen - neue Möglichkeiten für die Immuntherapie von Krebs] M. Leisegang W. Uckert April 01, 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber April 01, 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein July 03, 2013 in Sci Transl Med TCR-ligand k(off) rate correlates with the protective capacity of antigen-specific CD8(+) T cells for adoptive transfer M. Nauerth B. Weissbrich R. Knall T. Franz G. Dössinger J. Bet P.J. Paszkiewicz L. Pfeifer M. Bunse W. Uckert R. Holtappels D. Gillert-Marien M. Neuenhahn A. Krackhardt M.J. Reddehase S.R. Riddell D.H. Busch April 26, 2013 in PLoS ONE MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy G. Dössinger M. Bunse J. Bet J. Albrecht P.J. Paszkiewicz B. Weißbrich I. Schiedewitz L. Henkel M. Schiemann M. Neuenhahn W. Uckert D.H. Busch April 02, 2013 in Structure Structural insights into the mechanism of GTPase activation in the GIMAP family D. Schwefel B.S. Arasu S.F. Marino B. Lamprecht K. Köchert E. Rosenbaum J. Eichhorst B. Wiesner J. Behlke O. Rocks S. Mathas O. Daumke July 28, 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein Pagination Current page 1 Page 2 Next page Next › Last page Last »
July 01, 2017 in Canc Res Chimeric PD-1:28 receptor upgrades low-avidity T cells and restores effector function of tumor-infiltrating lymphocytes for adoptive cell therapy R. Schlenker L.F. Olguín-Contreras M. Leisegang J. Schnappinger A. Disovic S. Rühland P.J. Nelson H. Leonhardt H. Harz S. Wilde D.J. Schendel W. Uckert G. Willimsky E. Noessner
May 04, 2017 in Nature Tumour ischaemia by interferon-γ resembles physiological blood vessel regression T. Kammertoens C. Friese A. Arina C. Idel D. Briesemeister M. Rothe A. Ivanov A. Szymborska G. Patone S. Kunz D. Sommermeyer B. Engels M. Leisegang A. Textor H.J. Fehling M. Fruttiger M. Lohoff A. Herrmann H. Yu R. Weichselbaum W. Uckert N. Hübner H. Gerhardt D. Beule H. Schreiber T. Blankenstein
April 01, 2017 in Mol Cell Biol Activation-dependent TRAF3 exon 8 alternative splicing is controlled by CELF2 and hnRNP C binding to an upstream intronic element A.S. Schultz M. Preussner M. Bunse R. Karni F. Heyd
June 01, 2015 in BIOspektrum Designer T cells - New possibilities for immunotherapy of cancer [Designer-T-Zellen - neue Möglichkeiten für die Immuntherapie von Krebs] M. Leisegang W. Uckert
April 01, 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
April 01, 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
July 03, 2013 in Sci Transl Med TCR-ligand k(off) rate correlates with the protective capacity of antigen-specific CD8(+) T cells for adoptive transfer M. Nauerth B. Weissbrich R. Knall T. Franz G. Dössinger J. Bet P.J. Paszkiewicz L. Pfeifer M. Bunse W. Uckert R. Holtappels D. Gillert-Marien M. Neuenhahn A. Krackhardt M.J. Reddehase S.R. Riddell D.H. Busch
April 26, 2013 in PLoS ONE MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy G. Dössinger M. Bunse J. Bet J. Albrecht P.J. Paszkiewicz B. Weißbrich I. Schiedewitz L. Henkel M. Schiemann M. Neuenhahn W. Uckert D.H. Busch
April 02, 2013 in Structure Structural insights into the mechanism of GTPase activation in the GIMAP family D. Schwefel B.S. Arasu S.F. Marino B. Lamprecht K. Köchert E. Rosenbaum J. Eichhorst B. Wiesner J. Behlke O. Rocks S. Mathas O. Daumke
July 28, 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
